Loxtidine

Loxtidine
Systematic (IUPAC) name
[1-methyl-5-({3-[3-(piperidin-1-ylmethyl)phenoxy]propyl}amino)-1H-1,2,4-triazol-3-yl]methanol
Clinical data
  • Uncontrolled
Oral
Identifiers
76956-02-0
None
PubChem CID 55473
ChemSpider 50093
UNII X16K5179V5
Chemical data
Formula C19H29N5O2
359.47 g/mol

Lavoltidine (INN, USAN, BAN; code name AH-23,844), previously known as loxtidine, is a highly potent and selective H2 receptor antagonist which was under development as a treatment for gastroesophageal reflux disease but was discontinued due to the discovery that it produced gastric carcinoid tumors in rodents.[1][2]

See also

References

  1. Washington, Neena (1991). Antacids and anti-reflux agents. Boca Raton: CRC Press. ISBN 0-8493-5444-7.
  2. Dictionary of organic compounds. London: Chapman & Hall. 1996. ISBN 0-412-54090-8.